These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 14524737

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Safety aspects of treatment with lacidipine--a slow-onset, long-acting calcium antagonist.
    Lindholm LH, Tcherdakoff P, Zanchetti A.
    Blood Press; 1996 Jul; 5(4):241-9. PubMed ID: 8809376
    [Abstract] [Full Text] [Related]

  • 5. Lercanidipine : a review of its efficacy in the management of hypertension.
    Bang LM, Chapman TM, Goa KL.
    Drugs; 2003 Jul; 63(22):2449-72. PubMed ID: 14609358
    [Abstract] [Full Text] [Related]

  • 6. Evaluating the benefits of an antihypertensive agent using trials based on event and organ damage: the Systolic Hypertension in the Elderly Long-term Lacidipine (SHELL) trial and the European Lacidipine Study on Atherosclerosis (ELSA).
    Zanchetti A.
    J Hypertens Suppl; 1995 Dec; 13(4):S35-9. PubMed ID: 8824685
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Lacidipine. Aponil, Caldine, GR 43659, GR 43659X, GX 1048, Lacimen, Lacipil, Lacirex, Midotens, Motens, SN 305, Viapres.
    Drugs R D; 2002 Dec; 3(5):324-30. PubMed ID: 12455153
    [No Abstract] [Full Text] [Related]

  • 9. Safety of the calcium antagonist lacidipine evaluated from a phase III-IV trial database.
    Lindholm LH, Tcherdakoff P, Zanchetti A.
    J Hypertens Suppl; 1996 Sep; 14(2):S15-20. PubMed ID: 8934373
    [Abstract] [Full Text] [Related]

  • 10. Manidipine: a review of its use in hypertension.
    Cheer SM, McClellan K.
    Drugs; 2001 Sep; 61(12):1777-99. PubMed ID: 11693466
    [Abstract] [Full Text] [Related]

  • 11. Clinical position of lacidipine, a new dihydropyridine calcium antagonist, in the treatment of hypertension.
    Leonetti G.
    J Cardiovasc Pharmacol; 1991 Sep; 18 Suppl 11():S18-21. PubMed ID: 1725445
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Long-term antihypertensive treatment with lacidipine, a new long-acting calcium antagonist.
    Nami R, Rizzini P, Buracchi P, Pavese G, Gennari C.
    J Cardiovasc Pharmacol; 1991 Sep; 18 Suppl 11():S22-5. PubMed ID: 1725446
    [Abstract] [Full Text] [Related]

  • 14. Endothelial dysfunction, hypertension and atherosclerosis. A review of the effects of lacidipine.
    Haller H, Cosentino F, Lüscher TF.
    Drugs R D; 2002 Sep; 3(5):311-23. PubMed ID: 12455152
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Additive hypotensive effect of a dihydropyridine calcium antagonist to that produced by a thiazide diuretic: a double-blind placebo-controlled crossover trial with ambulatory blood pressure monitoring.
    Stergiou GS, Malakos JS, Achimastos AD, Mountokalakis TD.
    J Cardiovasc Pharmacol; 1997 Mar; 29(3):412-6. PubMed ID: 9125681
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.